PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
229.02 - 234.51
169.21 - 260.10
55.82M / 54.92M (Avg.)
32.24 | 7.26
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
98.50%
Net income growth above 1.5x VUZI's 43.04%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
25.37%
D&A growth of 25.37% while VUZI is zero at 0.00%. Bruce Berkowitz would see a mild cost difference that must be justified by expansions.
167.48%
Deferred tax of 167.48% while VUZI is zero at 0.00%. Bruce Berkowitz would see a partial difference that can matter for future cash flow if large in magnitude.
20.57%
SBC growth of 20.57% while VUZI is zero at 0.00%. Bruce Berkowitz would see some additional share issuance that must be justified by expansions or retention needs.
-67.68%
Both reduce yoy usage, with VUZI at -766.67%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
127.59%
AR growth well above VUZI's 100.00%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
213.89%
Some inventory rise while VUZI is negative at -100.00%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
-142.10%
Negative yoy AP while VUZI is 100.00%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
-93.58%
Both reduce yoy usage, with VUZI at -966.67%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
No Data
No Data available this quarter, please select a different quarter.
-8.31%
Both yoy CFO lines are negative, with VUZI at -280.95%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
16.35%
Lower CapEx growth vs. VUZI's 40.00%, potentially boosting near-term free cash. David Dodd would confirm no missed expansions that competitor might exploit.
No Data
No Data available this quarter, please select a different quarter.
-125.47%
Negative yoy purchasing while VUZI stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
8.80%
Liquidation growth of 8.80% while VUZI is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
-100.00%
We reduce yoy other investing while VUZI is 0.00%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-333.47%
We reduce yoy invests while VUZI stands at 40.00%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
No Data
No Data available this quarter, please select a different quarter.
6.94%
Issuance growth of 6.94% while VUZI is zero at 0.00%. Bruce Berkowitz sees a mild dilution that must be justified by expansions or acquisitions vs. competitor’s stable share base.
No Data
No Data available this quarter, please select a different quarter.